期刊文献+
共找到838篇文章
< 1 2 42 >
每页显示 20 50 100
Comparative analysis of cytomegalovirus retinitis and microvascular retinopathy in patients with acquired immunodeficiency syndrome 被引量:10
1
作者 Chao Chen Chun-Gang Guo +4 位作者 Li Meng Jing Yu Lian-Yong Xie Hong-Wei Dong Wen-Bin Wei 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2017年第9期1396-1401,共6页
AIM:To compare the clinical manifestation of cytomegalovirus(CMV)retinitis and microvascular retinopathy(MVR)in patients with acquired immunodeficiency syndrome(AIDS)in China.METHODS:A total of 93 consecutive ... AIM:To compare the clinical manifestation of cytomegalovirus(CMV)retinitis and microvascular retinopathy(MVR)in patients with acquired immunodeficiency syndrome(AIDS)in China.METHODS:A total of 93 consecutive patients with AIDS,including 41 cases of CMV retinitis and 52 cases of MVR were retrospectively reviewed.Highly active antiretroviral therapy(HAART)status was recorded.HIV and CMV immunoassay were also tested.CD4+T-lymphocyte count and blood CMV-DNA test were performed in all patients.Aqueous humor CMV-DNA test was completed in 39patients.Ophthalmological examinations including best corrected visual acuity(BCVA,by International Standard Vision Chart),intraocular pressure(IOP),slit-lamp biomicroscopy,indirect ophthalmoscopy were performed.RESULTS:In MVR group,the anterior segment examination was normal in all patients with a mean BCVA of 0.93±0.13.Blood CMV-DNA was 0(0,269 000)and 42 patients(80.77%)did not receive HAART.In CMV retinitis group,13 patients(31.71%)had anterior segment abnormality.The mean BCVA was 0.64±0.35 and blood CMV-DNA was 3470(0,1 450 000).Nineteen patients(46.34%)had not received HAART.MVR group and CMV retinitis group the positive rates of aqueous CMV-DNA were 0 and 50%,respectively.Two patients with MVR progressed to CMV retinitis during the follow-up period.CONCLUSION:In comparison of CMV,patients with MVR have relatively mild visual function impairment.Careful ophthalmological examination and close follow-up are mandatory,especially for patients who have systemic complications,positive CMV-DNA test and without received HAART. 展开更多
关键词 acquired immunodeficiency syndrome cytomegalovirus retinitis microvascular retinopathy CD4+ T-lymphocyte CMV-DNA highly active antiretroviral therapy
下载PDF
Salivary gland disease in human immunodeficiency virus/acquired immunodeficiency syndrome: A review
2
作者 Gaurav Sharma Archna Nagpal 《World Journal of Dermatology》 2015年第1期57-62,共6页
The effect of human immunodeficiency virus(HIV) infection on salivary glands has diagnostic and prognostic significance. HIV-salivary gland disease(HIV-SGD) is comprehensively ascertained amongst the major critical ac... The effect of human immunodeficiency virus(HIV) infection on salivary glands has diagnostic and prognostic significance. HIV-salivary gland disease(HIV-SGD) is comprehensively ascertained amongst the major critical acquired immunodeficiency syndrome(AIDS)-relatedoral manifestation and causes substantial morbidity. Parotid gland swelling due to sicca syndrome, parotid lipomatosis, sialadenitis, diffuse infiltrative lymphocytosis syndrome, benign lymphoepithelial lesions, neoplasms(benign or malignant) of salivary gland, parotid gland inflammation, diminished flow rates of saliva and xerostomia have been documented that also affects the health- associated characteristics of life in subjects infected with HIV. There is a necessity for health care researchers to diagnose it, particularly as it might worsen if left undiagnosed. The precise characteristic of alterations in dynamics of salivary gland structure and functionality with long-standing usage of highly active anti-retroviral therapy still remains unknown. HIV positive children also present with bilateral parotid enlargement and the syndrome state with classical clinical and cytological features of predominated lymphoid hyperplasia. Though various case reports and studies have been extensively published on different aspects of HIV-SGD, it has not been described solely, thus leading to occasional confusion of nomenclature and clinical presentation of HIV-SGD. This article reviews the pathogenesis of HIV-related SGD and its components and various other miscellaneous disorders affecting the salivary glands in HIV/AIDS. 展开更多
关键词 Human immunodeficiency virus acquired immunodeficiency syndrome SALIVARY GLAND diseases ANTIRETROVIRAL therapy Highly active XEROSTOMIA
下载PDF
An Experimental Model for Screening Anti-AIDS Drugs with Bovine Immunodeficiency Virus
3
作者 王岱 刘淑红 +3 位作者 陈启民 耿运琪 徐为人 魏月芳 《Journal of Chinese Pharmaceutical Sciences》 CAS 1997年第1期35-39,共5页
The assays for bovine immunodeficiency virus (BIV) induced syncytium formation and BIV long terminal repeat (LTR) directed luciferase (Luc) gene expression were applied to screen and evaluate anti AIDS drugs. Frequen... The assays for bovine immunodeficiency virus (BIV) induced syncytium formation and BIV long terminal repeat (LTR) directed luciferase (Luc) gene expression were applied to screen and evaluate anti AIDS drugs. Frequency of the syncytium formation and BIV LTR directed Luc activity were in proportion to the number of input BIV infected cells. AZT inhibited the syncytium formation and the BIV LTR directed Luc gene expression level. Its inhibitory effects were dosedependent with the IC 50 being 0.24 and 0.052 mmol / L, respectively. 展开更多
关键词 acquired immunodeficiency syndrome (aids) Drug screening Bovine immunodeficiency virus (BIV) SYNCYTIUM Long terminal repeat (LTR) 3′ Azido 2′ 3′ dide oxythymidine (AZT)
全文增补中
Bilateral Central Retinal Vein Occlusions Combined with Artery Occlusions in A Patient with Acquired Immune Deficiency Syndrome 被引量:3
4
作者 FengWen ChenXM 《Eye Science》 CAS 2002年第1X期27-29,共3页
Purpose: This is the first report of a bilateral nonischemic central retinal vein occlusionscombined with artery occlusions in a patient with acquired immune deficiency syndrome(AIDS). Methods: Case report. Results: A... Purpose: This is the first report of a bilateral nonischemic central retinal vein occlusionscombined with artery occlusions in a patient with acquired immune deficiency syndrome(AIDS). Methods: Case report. Results: A 22-year-old Chinese(male) with a positive human immunodeficiency virus(HIV) infection developed bilateral nonischemic central retinal vein occlusions combinedwith artery occlusions and severe vision loss. The manifestations of the fundus andfluorescein angiography were similar in both eyes.Conclusion: This case report provides the evidences that central retinal vein and arteryocclusions are probably part of the spectrum of AIDS vascular diseases. 展开更多
关键词 艾滋病 中心性视网膜血管闭塞 HIV
下载PDF
“零转介”AIDS诊疗管理模式的临床验证
5
作者 李娜 张坤 +3 位作者 赵丽娜 范子建 王立静 张雅楠 《河北医药》 CAS 2024年第10期1548-1551,共4页
目的探讨“零转介”诊疗管理模式对人类免疫缺陷病毒(HIV)感染患者治疗疗效和满意度的效果。方法选取石家庄市第五医院2022年7月至12月新增HIV感染者100例,随机分为对照组和研究组,每组50例。对照组给予常规认知干预和健康指导、心理干... 目的探讨“零转介”诊疗管理模式对人类免疫缺陷病毒(HIV)感染患者治疗疗效和满意度的效果。方法选取石家庄市第五医院2022年7月至12月新增HIV感染者100例,随机分为对照组和研究组,每组50例。对照组给予常规认知干预和健康指导、心理干预,研究组在确诊前较对照组提前7~10 d即给予认知干预、生活指导和心理干预。比较对照组和研究组患者的HIV感染患者睡眠[匹兹堡睡眠质量指数表(PSQI)]、服药依从性、焦虑抑郁量表分值。结果对照组患者的PSQⅠ评分高于研究组患者(P<0.01);研究组患者的焦虑抑郁的心理状况要优于对照组(P<0.05);对照组患者服药依从性良好者比例低于研究组患者(P<0.01);研究组患者对疾病的接受度和认知评定量表均好于对照组患者(P<0.01)。结论“零转介”模式,提前给予认知干预、生活指导和心理干预,可提高HIV感染患者满意度,对社会层面的AIDS预防具有积极意义。 展开更多
关键词 aids 零转介 诊疗体系 PSQI
下载PDF
艾博韦泰联合多替拉韦治疗HIV感染/AIDS多重耐药1例报道
6
作者 安永辉 杨萱 孙燕 《新发传染病电子杂志》 2024年第4期57-60,共4页
随着抗反转录病毒治疗(antiretroviral therapy,ART)的快速启动和推广,HIV感染已成为一种可以治疗的慢性传染病,然而治疗期间若ART不规范或患者依从性差可引起耐药变异。本研究报道1例30岁多重耐药HIV感染者使用艾博韦泰(albuvirtide,A... 随着抗反转录病毒治疗(antiretroviral therapy,ART)的快速启动和推广,HIV感染已成为一种可以治疗的慢性传染病,然而治疗期间若ART不规范或患者依从性差可引起耐药变异。本研究报道1例30岁多重耐药HIV感染者使用艾博韦泰(albuvirtide,ABT)联合多替拉韦(dolutegravir,DTG)的治疗经过。患者治疗失败后行HIV耐药检测,结果显示患者对核苷类逆转录酶抑制剂、非核苷类逆转录酶抑制剂及蛋白酶抑制剂中的多种药物存在不同程度耐药,在既往药物中仅对整合酶抑制剂类药物敏感。结合患者HIV耐药检测结果,治疗方案更换为“ABT+DTG”,患者病毒复制被成功抑制,且患者在8个月治疗过程中免疫功能逐步提升。而后因个人原因,患者短暂停用“ABT+DTG”治疗1个月,免疫水平下降,病毒载量出现反跳。后行“ABT+DTG”方案治疗至2023年3月,CD4^(+)T淋巴细胞计数平稳升高至291×10^(6)个/L,病毒载量持续降低至小于40×10^(3)copies/L,治疗期间患者耐受性及安全性较好。提示ABT联合DTG方案是HIV多重耐药患者一种新的治疗选择。 展开更多
关键词 艾博韦泰 人免疫缺陷病毒 艾滋病 多重耐药 抗反转录病毒治疗 病例报道
下载PDF
经抗病毒治疗的成年HIV感染/AIDS患者并发结核病预测模型的建立与验证
7
作者 王秋婷 陈燕 +2 位作者 陈赛娟 刘华 张燕 《检验医学与临床》 CAS 2024年第11期1520-1527,共8页
目的探讨经抗病毒治疗(ART)的成年人类免疫缺陷病毒(HIV)感染/获得性免疫缺陷综合征(AIDS)患者并发结核病(TB)的影响因素,构建列线图模型预测HIV感染/AIDS患者并发TB风险。方法对2017年2月至2021年2月于重庆市公共卫生医疗救治中心接受... 目的探讨经抗病毒治疗(ART)的成年人类免疫缺陷病毒(HIV)感染/获得性免疫缺陷综合征(AIDS)患者并发结核病(TB)的影响因素,构建列线图模型预测HIV感染/AIDS患者并发TB风险。方法对2017年2月至2021年2月于重庆市公共卫生医疗救治中心接受ART的1486例HIV感染/AIDS患者进行回顾性研究。采用单因素、多因素Logistic回归分析HIV感染/AIDS患者并发TB的独立危险因素并构建列线图预测模型。绘制受试者工作特征曲线、校准曲线和决策曲线进行内、外部验证,评价模型预测效能和临床实用性。结果男性、开始ART年龄为18~<45岁、世界卫生组织临床分期为Ⅲ期或Ⅳ期、基线CD4+T淋巴细胞计数为200~<350个/μL或<200个/μL、基线病毒载量为10000~100000 copy/mL或>100000 copy/mL和贫血是HIV感染/AIDS患者并发TB的独立危险因素(P<0.05)。训练集及测试集列线图预测模型内外部验证的曲线下面积分别为0.727(95%CI:0.696~0.758)、0.780(95%CI:0.722~0.838)。校准曲线拟合效果良好,决策曲线分析结果显示该模型具有良好的临床收益。结论基于上述独立危险因素建立的HIV感染/AIDS患者并发TB风险的列线图预测模型具有较强的预测效能,能够为早期降低TB发病风险提供科学依据。 展开更多
关键词 人类免疫缺陷病毒感染 获得性免疫缺陷综合征 结核病 抗病毒治疗 危险因素 列线图模型
下载PDF
AIDS病人/HIV感染者孤独感研究进展
8
作者 韩贇 柯欢 +3 位作者 张立秀 王伟洪 王淑婵 林淑洁 《护理研究》 北大核心 2024年第6期1026-1030,共5页
对艾滋病(AIDS)病人/人类免疫缺陷病毒(HIV)感染者孤独感的概念、机制、现状、评估工具、影响因素以及干预措施进行综述,旨在为今后对AIDS病人/HIV感染者进行心理干预,促进其身心健康提供参考。
关键词 艾滋病(aids) 人类免疫缺陷病毒(HIV) 孤独感 护理 综述
下载PDF
基线CD4^(+)T淋巴细胞计数水平与HIV/AIDS患者抗病毒治疗后免疫重建结局的关系研究
9
作者 颜新爽 秦玉荣 王素芳 《临床和实验医学杂志》 2024年第4期373-377,共5页
目的探讨基线CD4^(+)T淋巴细胞计数水平与人类免疫缺陷病毒/获得性免疫缺陷综合征(HIV/AIDS)患者抗病毒治疗后免疫重建结局的关系。方法回顾性选取2021年9月至2022年3月中国科学技术大学附属第一医院(安徽省立医院)感染科收治的新确诊HI... 目的探讨基线CD4^(+)T淋巴细胞计数水平与人类免疫缺陷病毒/获得性免疫缺陷综合征(HIV/AIDS)患者抗病毒治疗后免疫重建结局的关系。方法回顾性选取2021年9月至2022年3月中国科学技术大学附属第一医院(安徽省立医院)感染科收治的新确诊HIV/AIDS的患者110例,所有患者均接受高效抗逆转录病毒治疗(HAART),对患者进行1年随访,按照末次随访CD4^(+)T淋巴细胞计数<200个/μL或增长未超过基线的20%作为判定免疫重建不良的标准,对患者免疫重建结局进行分组,其中78例患者纳入免疫重建良好组,32例患者纳入免疫重建不良组,对患者治疗前后不同时间的CD4^(+)、CD8^(+)T淋巴细胞计数水平进行监测,并探究影响患者免疫重建结局的影响因素。结果治疗后3、6、9、12个月时,免疫重建不良组患者的病毒载量分别为26983(456,52239)、9126(316,14012)、1622(215,4501)、212(98,325)拷贝/mL,均高于免疫重建良好组[21598(412,48236)、6533(264,9154)、1231(152,2105)、135(52,287)拷贝/mL],差异均有统计学意义(P<0.05)。两组患者治疗前后各时间段的CD8^(+)T淋巴细胞计数水平组间比较,差异均无统计学意义(P>0.05)。单因素分析结果显示,感染途径、性别、学历水平、婚姻状态对其免疫重建效果无影响(P>0.05),年龄偏大、确诊至治疗时间在1年以上、基线CD4^(+)T淋巴细胞水平低、基线病毒载量高均会对患者的免疫重建效果产生负面影响(P<0.05)。多因素Logistic回归分析结果显示,年龄偏大、确诊至治疗时间在1年以上、基线CD4^(+)T淋巴细胞水平低、基线病毒载量高均会影响患者的免疫重建效果(OR=2.567,95%CI:1.075~6.127;OR=4.067,95%CI:1.690~9.785;OR=2.550,95%CI:1.096~5.934;OR=2.816,95%CI:1.203~6.591)。结论较高的基线CD4^(+)T淋巴细胞计数水平、较低的病毒载量有利于HIV/AIDS患者抗病毒治疗后的免疫重建,而基线CD4^(+)T淋巴细胞计数水平的低下可能是免疫重建不良的重要危险因素。 展开更多
关键词 淋巴细胞 HIV 获得性免疫缺陷综合征 抗病毒治疗 免疫重建
下载PDF
PBMCs中miR-21、miR-223表达与HIV/AIDS患者抗逆转录病毒治疗效果的相关性
10
作者 匡宁 刘超 +2 位作者 计然然 蒋华春 许翼 《中国性科学》 2024年第1期153-156,共4页
目的探讨人类免疫缺陷病毒(HIV)/获得性免疫缺陷综合征(AIDS)患者抗逆转录病毒治疗效果与外周血单个核细胞(PBMCs)中微小RNA(miR)-21、miR-223表达水平的关系。方法选取2020年3月至2022年3月期间南通市第三人民医院门诊就诊行抗逆转录... 目的探讨人类免疫缺陷病毒(HIV)/获得性免疫缺陷综合征(AIDS)患者抗逆转录病毒治疗效果与外周血单个核细胞(PBMCs)中微小RNA(miR)-21、miR-223表达水平的关系。方法选取2020年3月至2022年3月期间南通市第三人民医院门诊就诊行抗逆转录病毒治疗的142例HIV/AIDS患者为观察组,根据其治疗效果分为有效组(n=110)和无效组(n=32);选取同期体检健康者139例为对照组。采用实时荧光定量聚合酶链反应法检测PBMCs中miR-21、miR-223表达水平;采用多因素Logistic回归分析HIV/AIDS患者抗逆转录病毒治疗无效的影响因素。结果观察组PBMCs中miR-21、miR-223表达水平高于对照组(P<0.05)。无效组治疗后3个月、治疗后6个月、治疗后12个月的PBMCs中miR-21、miR-223表达水平均高于有效组(P<0.05)。有效组随治疗时间延长,PBMCs中miR-21、miR-223表达水平逐渐降低(P<0.05)。无效组治疗前世界卫生组织(WHO)分期3期患者比例高于有效组(P<0.05)。miR-21、miR-223、治疗前WHO分期3期是影响HIV/AIDS患者抗逆转录病毒治疗无效的独立危险因素(P<0.05)。结论miR-21、miR-223在一定程度上可反映HIV/AIDS患者抗逆转录病毒治疗效果,治疗无效患者PBMCs中miR-21、miR-223表达水平相对较高。 展开更多
关键词 人类免疫缺陷病毒/获得性免疫缺陷综合征 抗逆转录病毒治疗 外周血单个核细胞 微小RNA-21 微小RNA-223
下载PDF
Ocular manifestation and their associated factors among HIV/AIDS patients receiving highly active antiretroviral therapy in Southern Ethiopia 被引量:2
11
作者 Anteneh Amsalu Kindie Desta +1 位作者 Demiss Nigussie Demoze Delelegne 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2017年第5期776-781,共6页
AIM:To assess the pattern of ocular manifestation and associated factors among human immunodeficiency virus(HIV)/acquired immunodeficiency syndrome(AIDS) patients on highly active antiretroviral therapy(HAART) ... AIM:To assess the pattern of ocular manifestation and associated factors among human immunodeficiency virus(HIV)/acquired immunodeficiency syndrome(AIDS) patients on highly active antiretroviral therapy(HAART) at Hawassa University Referral Hospital, Southern Ethiopia. METHODS:A cross sectional study was conducted from January 2014 to April 2015. After obtaining informed written consent, 240 adult HIV/AIDS patients on HAART were randomly selected regardless of their ophthalmic symptoms, WHO status or CD4 count. Data were collected using structured questionnaires and ophthalmologic clinical examination. Data were entered and analyzed using SPSS version 20.0 software. RESULTS:The mean duration of HAART was 62.5mo. The prevalence of HIV related ocular manifestation was 14.2%. Seborrheic blepharitis(5%) was the most common ocular manifestation, followed by squamoid conjunctival growth(3.8%). The rate of ocular manifestation was significantly higher among study participants who had CD4+ count 〈200 cells/μL(AOR=3.83; 95%CI:1.315-11.153), low duration of HAART(AOR=3.0; 95%CI:1.305-6.891) and who had primary school education [odds ratio(OR) =2.8; 95%CI:1.105-7.099]. Prevalence of visual impairment and blindness was 10.9% and 5.8%, respectively.CONCLUSION:HAART may be the reason for the decline in the prevalence of ocular manifestation in HIV/AIDS patients in the study area. Ophthalmologic screening of HIV/AIDS patients, especially those with CD4 counts of 〈200/μL cells and in the first five years of HAART followup is recommended to reduce visual impairment and/or blindness. 展开更多
关键词 human immunodeficiency virus acquired immunodeficiency syndrome ocular manifestation highlyactive antiretroviral therapy
下载PDF
Elevated homocysteine levels in human immunodeficiency virus-infected patients under antiretroviral therapy: A meta-analysis 被引量:2
12
作者 Rafael Deminice Talita Capoani Vieira Silva Vitor Hugo Fernando de Oliveira 《World Journal of Virology》 2015年第2期147-155,共9页
AIM: To evaluate the association between the levels of homocysteine(Hcy), folate, vitamin B12 in human immunodeficiency virus(HIV)-infected patients who were treated with antiretroviral therapy(ART) or not treated wit... AIM: To evaluate the association between the levels of homocysteine(Hcy), folate, vitamin B12 in human immunodeficiency virus(HIV)-infected patients who were treated with antiretroviral therapy(ART) or not treated with ART.METHODS: The Pub Med and Scielo databases were searched. Eligible studies regarding plasma Hcy level in HIV-infected patients were firstly identified. After careful analysis by two independent researches, the identified articles were included in the review according to two outcomes(1) Hcy, folate and vitamin B12 blood concentration in HIV-infected subjects vs health controls and;(2) Hcy blood concentration in HIV-infected subjects under ART vs not treated with ART. RevM an(version 5.2) was employed for data synthesis.RESULTS: A total of 12 studies were included in outcome 1(1649 participants, 932 cases and 717 controls). Outcome 1 meta-analysis demonstrated higher plasma Hcy(2.05 μmol/L; 95% CI: 0.10 to 4.00, P < 0.01) and decreased plasma folate concentrations(-2.74 ng/m L; 95%CI:-5.18 to-0.29, P < 0.01) in HIV-infected patients compared to healthy controls. No changes in vitamin B12 plasma concentration were observed between groups. All studies included in the outcome 2 meta-analysis(1167 participants; 404 HIVinfected exposed to ART and 757 HIV-infected non-ART patients) demonstrated higher mean Hcy concentration in subjects HIV-infected under ART compared to nonART HIV subjects(4.13 μmol/L; 95%CI: 1.34 to 6.92, P < 0.01).CONCLUSION: This meta-analysis demonstrated that the levels of Hcy and folate, but not vitamin B12, were associated with HIV infection. In addition, Hcy levels were higher in HIV-infected patients who were under ART compared to HIV-infected patients who were not exposed to ART. Our results suggest that hyperhomocysteinemia should be included among the several important metabolic disturbances that are associated with ART in patients with HIV infection. 展开更多
关键词 ANTIRETROVIRAL therapy HOMOCYSTEINE Folate VITAMIN B12 Human immunodeficiency virus acquired immune deficiency syndrome
下载PDF
中医药治疗HIV/AIDS相关腹泻疗效和安全性的Meta分析与GRADE证据评价
13
作者 温敏 张丽琴 +3 位作者 袁燕 王蕊 戚云迪 杜玉鹏 《新中医》 CAS 2024年第19期183-191,共9页
目的:系统评价中医药治疗人类免疫缺陷病毒感染或获得性免疫缺陷综合征(HIV/AIDS)相关腹泻(HRD)的临床疗效和安全性,并进行GRADE证据质量评价。方法:检索中国知网(CNKI)、PubMed等中英文数据库和临床试验注册平台,检索中医药治疗HRD的... 目的:系统评价中医药治疗人类免疫缺陷病毒感染或获得性免疫缺陷综合征(HIV/AIDS)相关腹泻(HRD)的临床疗效和安全性,并进行GRADE证据质量评价。方法:检索中国知网(CNKI)、PubMed等中英文数据库和临床试验注册平台,检索中医药治疗HRD的随机对照试验(检索时间从各个数据库建库至2023年3月31日),由2名研究人员独立进行数据检索、数据提取、偏倚风险评价和Meta分析。结果:最终纳入31篇文献和1项临床研究,共计3474例患者,其中试验组1830例,对照组1644例。Meta分析结果显示,中医药治疗能显著提高HRD患者的临床疗效有效率,降低大便次数积分、中医症状积分、腹泻量表积分、腹痛积分,加快腹泻消失时间,增加体质量。临床疗效有效率和中医症状积分均未发现发表偏倚。GRADE证据质量评价结果显示:中医症状积分、大便次数积分、CD4+T细胞绝对数量为高级质量证据;临床疗效有效率、腹泻恢复时间、腹泻量表积分、腹痛积分、不良反应发生率和体质量为中级质量证据;中医证候临床疗效有效率为低级质量证据。结论:中医药能提高HRD患者的临床疗效有效率,改善腹泻临床症状,且安全性较好,推荐使用于HRD的治疗。但由于所纳入的研究方法质量较低和部分结局指标证据质量较低,尚需更多设计严谨的多中心随机对照试验增加证据强度。 展开更多
关键词 人类免疫缺陷病毒 获得性免疫缺陷综合征 HIV/aids相关腹泻 中医药 META分析 GRADE评价
下载PDF
Effect of treatment course of comprehensive intervention with Traditional Chinese Medicine on mortality of acquired immunodeficiency syndrome patients treated with combined antiretroviral therapy 被引量:11
14
作者 Guo Huijun Wang Jian +3 位作者 Li Zhengwei Jiang Ziqiang Xu Qianlei Xu Liran 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2016年第4期411-417,共7页
OBJECTIVE:To investigate the effect of a treatment course of comprehensive intervention with Traditional Chinese Medicine(TCM) on the mortality of patients with acquired immunodeficiency syndrome(AIDS) treated with co... OBJECTIVE:To investigate the effect of a treatment course of comprehensive intervention with Traditional Chinese Medicine(TCM) on the mortality of patients with acquired immunodeficiency syndrome(AIDS) treated with combined antiretroviral therapy(c ART).METHODS:AIDS patients who had taken c ART in a national TCM human immunodeficiency virus treatment trial program(NTCMTP) before 2009 were enrolled in this study and followed for 36 months from November 2009.Patients enrolled in the NTCMTP in 2004 were taken as the first group,those enrolled in 2006 as the second group,and those enrolled in 2009 as the third group.Cumulative survival rates were calculated by the life table method.Survival curves for subgroups were compared by the log-rank test.Hazard ratios were calculated with a Cox proportional hazards model.RESULTS:A total of 1443 AIDS patients were followed for 3 years(4198 person-years).During this period,91(6.3%) patients died and 13(0.9%) were lost to follow-up.The total mortality rate was 2.17/100 person-years.The mortality rate of patients enrolled in the NTCMTP in 2004 was 1.49/100 person-years,which was lower than that of patients enrolled in 2006(2.23/100 person-years) and 2009(3.48/100 person-years).After adjusting for other factors,a shorter time of treatment with TCM,male sex,older age,lower CD4 + T-cell counts,and long-term treatment with c ART were risk factors of mortality.CONCLUSION:Long-term treatment with TCM decreased the mortality risk of AIDS patients.Factors such as being male,older age,CD4+ T-cell counts,and time of treatment with TCM and c ART were correlated with mortality. 展开更多
关键词 acquired immunodeficiency syndrome Antiretroviral therapy highly active MORTALITY MEDICINE Chinese traditional Retrospective cohort study
原文传递
Prevalence of liver injury among patients with acquired immunodeficiency syndrome treated with highly active antiretroviral therapy in China 被引量:5
15
作者 Yuan Jun Xu Qianlei +6 位作者 Chen Xiumin Meng Pengfei Li Qingya Xu Liran Meng Xiangle Jin Yantao Guo Huijun 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2019年第2期275-280,共6页
OBJECTIVE: To estimate the prevalence of liver injury among patients with acquired immunodeficiency syndrome(AIDS) who received highly active antiretroviral therapy(HAART) in rural Henan Province in China, and to expl... OBJECTIVE: To estimate the prevalence of liver injury among patients with acquired immunodeficiency syndrome(AIDS) who received highly active antiretroviral therapy(HAART) in rural Henan Province in China, and to explore whether Traditional Chinese Medicine(TCM) treatment based on HAART would increase this risk.METHODS: This was a retrospective cross-sectional study. We collected medical information on patients with AIDS from two treatment databases in2014. Criteria established by the AIDS Clinical Trials Group in 1996 were used for grading liver injury,classified based on the limit of normal(ULN) for alanine transaminase and aspartate aminotransferase:grade 1(1.25-2.5 × ULN); grade 2(2.6-5 × ULN);grade 3(5.1-10 × ULN); and grade 4(> 10 × ULN).Factors associated with liver injury were evaluated using a logistic regression model.RESULTS: A total 6953 patients with AIDS(3324 male and 3629 female patients) were enrolled into this study. The prevalence of liver injury was 22.0%(18.0% grade 1, 3.1% grade 2, 0.9% grade 3). In multivariate analysis, patients aged 34-45 years were more likely to have liver injury than patients in other age groups [adjusted odds ratio(AOR), 1.39; 95%CI, 1.01-1.91)]. Other factors associated with liver injury included male sex(AOR, 1.64; 95% CI,1.46-1.85), HIV infection via blood(AOR, 1.47; 95%CI, 1.19-1.82), hepatitis B virus antibody positive(AOR, 1.07; 95% CI, 0.85-1.36), and hepatitis C virus(HCV) antibody positive(AOR, 2.76; 95% CI,2.28-3.34).CONCLUSION: The prevalence of liver injury was relatively high among HAART-experienced patients. Several factors associated with liver injury included male sex, age 35-45 years old, HIV infection through blood, and concurrent HCV infection. TCM had no relationship with liver injury in patients receiving HAART. 展开更多
关键词 acquired immunodeficiency syndrome Chemical and drug induced liver INJURY PREVALENCE ANTIRETROVIRAL therapy highly active Medicine Chinese traditional
原文传递
AIDS并发巨细胞病毒性视网膜炎 被引量:18
16
作者 王焕玲 叶俊杰 +3 位作者 李太生 盛瑞媛 邱志峰 王爱霞 《中国艾滋病性病》 CAS 2003年第4期193-196,共4页
目的 探讨艾滋病 (AIDS)并发巨细胞病毒 (CMV)性视网膜炎的临床特点和治疗转归。方法 观察分析北京协和医院确诊为AIDS并发CMV视网膜炎的 5例患者的临床和实验室资料、治疗转归。结果  5例CMV视网膜炎患者的 9只眼均经眼底散瞳检查... 目的 探讨艾滋病 (AIDS)并发巨细胞病毒 (CMV)性视网膜炎的临床特点和治疗转归。方法 观察分析北京协和医院确诊为AIDS并发CMV视网膜炎的 5例患者的临床和实验室资料、治疗转归。结果  5例CMV视网膜炎患者的 9只眼均经眼底散瞳检查确诊。全部患者均为AIDS晚期患者 ,CD+ 4 T淋巴细胞计数 3~ 36 /mm3 ,在确诊CMV视网膜炎时均已合并其它机会性感染。平均年龄 2 9 2± 5 1岁。临床症状有视物模糊、视力下降等。眼底检查有典型的视网膜血管炎 ,表现为沿血管分布的黄白色病损、黄白色颗粒及视网膜出血 ,但玻璃体透明或轻微混浊。 4例接受更昔洛韦 (GCV)治疗的患者病情均得到控制 ,眼底病变消退 ,但其中 1例视力丧失 (失明 )无法恢复 ;1例患者未特殊治疗死于多种机会感染。结论 中国CMV视网膜炎的表现和国外文献报道的类似 ,多发生于晚期AIDS患者 ,不及时治疗将导致视力丧失 ,早期诊治非常重要。建议 :对于CD+ 4 T细胞计数 <5 0 /mm3 以及存在眼外CMV感染的AIDS患者 ,应常规作眼底检查 ;反之 ,对于拟诊CMV视网膜炎的所有患者 ,均应常规筛查血清HIV抗体。 展开更多
关键词 aids 巨细胞病毒性视网膜炎 并发症 艾滋病 治疗 转归
下载PDF
家庭关怀度对接受高效联合抗反转录病毒治疗HIV/AIDS患者服药依从性影响的研究 被引量:22
17
作者 刘聪 周凯 +6 位作者 何浩岚 徐国红 李永红 陈丽娟 罗灿伟 蔡卫平 李凌华 《中国护理管理》 CSCD 2017年第10期1405-1409,共5页
目的 :分析家庭关怀度对接受高效联合抗反转录病毒治疗(HAART)的HIV/AIDS患者服药依从性的影响。方法 :便利抽取112例在门诊接受国家免费HAART 1~95个月的HIV/AIDS患者,采用家庭关怀指数问卷和Morisky用药依从性问卷(MMAS-8)调查其家庭... 目的 :分析家庭关怀度对接受高效联合抗反转录病毒治疗(HAART)的HIV/AIDS患者服药依从性的影响。方法 :便利抽取112例在门诊接受国家免费HAART 1~95个月的HIV/AIDS患者,采用家庭关怀指数问卷和Morisky用药依从性问卷(MMAS-8)调查其家庭关怀度及服药依从性,使用Logistic回归分析家庭关怀度及各维度对服药依从性的影响。结果 :HAART的HIV/AIDS患者家庭关怀度总分为(7.26±2.75)分,其中家庭关怀良好占62.5%;HAART的HIV/AIDS患者服药依从性得分为(6.94±1.20)分,其中依从性好占33.9%,中等及以下占66.1%;家庭关怀总分及家庭关怀度中的适应度、合作度影响患者服药依从性,是HIV/AIDS患者服药依从性的影响因素。结论 :家庭关怀度是影响HIV/AIDS患者HAART依从性的重要因素,可通过鼓励患者家属与其共同面对感染HIV的事实,共同作出服药的决定,及提高其解决问题的能力等方式,提高患者服药依从性。 展开更多
关键词 艾滋病 高效抗反转录病毒治疗 HIV 服药依从性 家庭关怀
下载PDF
HIV/AIDS皮肤病变的临床分析 被引量:9
18
作者 王辉 胡毅文 +3 位作者 李丽雄 徐六妹 王火生 周伯平 《中国皮肤性病学杂志》 CAS 北大核心 2004年第7期421-422,共2页
目的 探讨HIV/AIDS患者皮肤粘膜病变的临床特征及其与疾病进展的相关性。方法 对45例HIV/AIDS患者的皮肤病变进行临床分析,并同时检测其CD4细胞计数与HIV病毒载量。结果 45例HIV/AIDS患者中有30创(66.7%)伴有皮肤病变,其中以真菌和疱... 目的 探讨HIV/AIDS患者皮肤粘膜病变的临床特征及其与疾病进展的相关性。方法 对45例HIV/AIDS患者的皮肤病变进行临床分析,并同时检测其CD4细胞计数与HIV病毒载量。结果 45例HIV/AIDS患者中有30创(66.7%)伴有皮肤病变,其中以真菌和疱疹病毒感染引起的皮肤病最常见,各占66.7%;其次为脂溢性皮炎,占36.7%;其它类型的皮肤病占50.0%。90.0%的AIDS皮肤病变发生在CD4细胞数<200个/μl,HIV-RNA载量>4 log。而HIV/且AIDS皮肤病变随着HARRT治疗后而缓解。结论 HIV/AIDS皮肤病变发生率很高,早期诊断与治疗对于监测HIV/AIDS患者疾病的进展有重大意义。 展开更多
关键词 获得性免疫缺陷综合征 皮肤病 高效抗逆转录病毒治疗
下载PDF
两种HAART方案对HIV/AIDS患者血脂的影响 被引量:12
19
作者 李虹 陈媛媛 +4 位作者 何云 李超锋 刘春礼 孙燕 赵清霞 《重庆医学》 CAS CSCD 北大核心 2014年第20期2574-2576,共3页
目的观察两种高效抗逆转录病毒治疗(HAART)方案应用48周对HIV/AIDS患者血脂的影响。方法将102例HIV/AIDS患者根据不同的HAART方案分为司他夫定(D4T)组[D4T联合拉米夫定(3TC)及奈韦拉平(NVP)治疗]和齐多夫定(AZT)组(AZT联合3TC及NVP治疗... 目的观察两种高效抗逆转录病毒治疗(HAART)方案应用48周对HIV/AIDS患者血脂的影响。方法将102例HIV/AIDS患者根据不同的HAART方案分为司他夫定(D4T)组[D4T联合拉米夫定(3TC)及奈韦拉平(NVP)治疗]和齐多夫定(AZT)组(AZT联合3TC及NVP治疗)。检测基线及HAART后24、48周时的三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)水平。结果配对t检验分析,D4T组患者24周TG、TC和LDL-C均显著升高(P<0.05),48周TC仍持续升高(P<0.05);AZT组24周TC和TG显著升高(P<0.05)。独立t检验分析,24、48周两组间比较血脂各项指标差异无统计学意义(P>0.05)。结论包含D4T和AZT的HAART方案均可导致HIV/AIDS患者血脂异常,主要是TG和TC升高,均以边缘升高为主。应用包含D4T的方案的HIV/AIDS患者TG和TC升高较早,并且TC升高后持续保持在较高的水平。 展开更多
关键词 抗逆转录病毒治疗 高效 获得性免疫缺陷综合征 血脂
下载PDF
HIV/AIDS患者体力活动现状及血脂异常影响因素研究 被引量:8
20
作者 赵艳伟 宋晓璟 +2 位作者 余旻虹 杨慧 绳宇 《中国护理管理》 CSCD 北大核心 2019年第12期1770-1774,共5页
目的:分析接受高效抗逆转录病毒治疗的HIV/AIDS患者体力活动现状及血脂异常影响因素。方法:采用一般情况调查表、国际体力活动问卷,对某院就诊的306例HIV/AIDS患者进行调查,同时检测血清胆固醇、甘油三酯、高密度脂蛋白和低密度脂蛋白... 目的:分析接受高效抗逆转录病毒治疗的HIV/AIDS患者体力活动现状及血脂异常影响因素。方法:采用一般情况调查表、国际体力活动问卷,对某院就诊的306例HIV/AIDS患者进行调查,同时检测血清胆固醇、甘油三酯、高密度脂蛋白和低密度脂蛋白。结果:本研究中不同性别的患者体力活动等级分布差异有统计学意义(P=0.014);血脂异常发生率为58.50%,其中高胆固醇血症发生率为5.56%,高甘油三酯血症发生率为20.59%,低高密度脂蛋白血症发生率为35.29%;男性血脂异常发生率随年龄呈上升趋势;多因素分析显示,高胆固醇血症与患者的性别(P=0.041)、年龄(P=0.008)、治疗前病毒载量(P=0.004)以及体力活动分数(P=0.019)均相关;高甘油三酯血症仅与体质指数(BMI)(P=0.002)和治疗前CD4+T淋巴细胞计数(P=0.048)相关;低高密度脂蛋白血症与BMI(P=0.010)、体力活动分数(P=0.046)及治疗前CD4+T淋巴细胞计数(P=0.043)相关;血脂异常与BMI(P=0.002)相关。结论:接受高效抗逆转录病毒治疗的HIV/AIDS患者血脂水平与年龄、BMI、治疗前CD4+T淋巴细胞计数及体力活动水平密切相关。护理人员应针对性地提供健康指导和血脂监测,改善患者活动习惯,从而减少高脂血症的发生。 展开更多
关键词 抗病毒治疗 获得性免疫缺陷综合征 血脂异常 体力活动 生活方式
下载PDF
上一页 1 2 42 下一页 到第
使用帮助 返回顶部